Glenn Wilkins - Tuesday, April 24, 2018 Tetra Bio-Pharma Inc. 10:56 AM EST - Tetra Bio-Pharma Inc. : Has signed a first binding term sheet for the marketing and distribution of PPP001 in Israel with Kamada Ltd., a leading pharmaceutical company. The signing of a Definitive Distribution Agreement is expected to follow shortly. PPP001 is being developed to be the first smokable cannabis product for advanced cancer pain available under prescription. Tetra Bio-Pharma Inc. shares V.TBP are trading up $0.03 at $0.76.